Call Us Today @ 0172 - 4680800 | info@indswift.com | NSE - BSE
Corona Remedies acquires two brands from Abbott
 
Ahmedabad: City-based pharma firmCorona Remedies today announced the acquisition of Obimet andThyrocab brands, comprising of 14 product line extensions, from Abbott India.
Both these brands are popular prescription drugs to manage diabetes and hyperthyroidism, Tejas Kothari, Head-Strategy at Corona said.

"This is the second brand acquisition by the company in the past year. Both these brands acquired by us are expected to garner a sales revenue of around Rs 25 crore in the first year of integration," Kothari told media persons here today while making the announcement.

In addition to the acquisitions, the company has also announced to set up its second manufacturing facility at Bavla village near Ahmedabad.

At present, the company is having its manufacturing facility in Himachal Pradesh.

"Our existing plant in Himachal Pradesh is having a manufacturing capacity of 100 crore tablets, 6 crore capsules and one crore liquid bottles per annum," said Vijay Charlu, vice president of sales and marketing.
"Now, we are setting up our second plant at Bavla with an investment of Rs 60 crore. The new plant will mostly cater to the European market. It will become operational by the end of 2019. This plant will produce 200 crore tablets, 60 crore capsules and 3 crore liquid bottles" said Charlu.

(Et health world)
 
Other Related News:
FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors
India plans measures to facilitate drug exports
Most Smokers With Head and Neck Cancer Have Tried to Quit
Scientists identify connection between dopamine and behavior related to pain and fear
Digital disruption in clinical trials
INS partners with WCEA to offer high-quality, infusion therapy-related education to nursing professionals around globe
Cipla arm recalls multiple lots of antidepressant drug from US
The collapse of the Venezuelan health system
Ranbaxy's demise wake-up call for business families in India
Corona Remedies acquires two brands from Abbott